CD274 and neoplasm: Having established 11B12-1 as a functional in vivo anti-PD-L1 mAb, we then evaluated safety, toxicity and anti-tumour efficacy when combining 11B12-1 with an oncolytic virotherapy (Ad5/3-E2F-D24-hTNFα-IRES-hIL2).